Market Place
Sourcing Support
All News #Library
Biotech
Cellectar Biosciences To Present Subset Of CLOVER Wam Trial Data
21 Apr 2026 //
FIRSTWORD PHARMA
Cellectar Initiates CLR 125 Trial For (TNBC) In Phase 1B
14 Apr 2026 //
GLOBENEWSWIRE
Cellectar Biosciences To Present Full-Year Financial Results
25 Feb 2026 //
GLOBENEWSWIRE
Cellectar Bio Showcases 2026 Strategy At JP Morgan Conference
09 Jan 2026 //
GLOBENEWSWIRE
Cellectar Bio Inks Actinium-225 Deal With Ionetix
16 Dec 2025 //
GLOBENEWSWIRE
Cellectar Biosciences Reports Q3 Results, Hosts Earnings Call
06 Nov 2025 //
GLOBENEWSWIRE
Cellectar Bio Raises $5.8M Through Agreements
07 Oct 2025 //
GLOBENEWSWIRE
Cellectar Bio Showcases Strong Data At AACR Pediatric Cancer
30 Sep 2025 //
GLOBENEWSWIRE
Cellectar Biosciences, ITM Ink GMP-Grade Actinium-225 Supply Deal
11 Sep 2025 //
GLOBENEWSWIRE
Cellectar Biosciences to Report Q2 Financial Results
07 Aug 2025 //
GLOBENEWSWIRE
Cellectar To Highlight 2025 Plan At JP Morgan Healthcare Conference
12 Jan 2025 //
GLOBENEWSWIRE
Cellectar lays off 60%, drops radiotherapy over new trial demand
11 Dec 2024 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.